Fu S, Guo Y, Peng Z, Zhang D, Chang Z, Xiao Y
Med Oncol. 2024; 42(1):25.
PMID: 39652257
PMC: 11628578.
DOI: 10.1007/s12032-024-02549-5.
Chen Y, Gong S, Tang J, Wang X, Gao Y, Yang H
Stem Cell Rev Rep. 2024; 21(2):509-519.
PMID: 39560864
DOI: 10.1007/s12015-024-10825-0.
Zhang K, Liu D, Li Y, Shi Z, Guo J, Gao C
Haematologica. 2023; 108(8):2116-2129.
PMID: 36632737
PMC: 10388288.
DOI: 10.3324/haematol.2022.281955.
Zhan Q, Zhang H, Wu B, Zhang N, Zhang L
Front Physiol. 2022; 13:1004330.
PMID: 36439256
PMC: 9691902.
DOI: 10.3389/fphys.2022.1004330.
Chen H, Bai Y, Kobayashi M, Xiao S, Cai W, Barajas S
Blood. 2022; 141(3):244-259.
PMID: 36206490
PMC: 9936309.
DOI: 10.1182/blood.2022016580.
Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches.
Geissler K
Front Oncol. 2021; 11:751668.
PMID: 34660314
PMC: 8514979.
DOI: 10.3389/fonc.2021.751668.
Rs4911154 of circ-ITCH aggravated tumor malignancy of thyroid nodules via the circ-ITCH/miR-22-3p/CBL axis.
Guo Y, Zheng H, Yin J, Wang H
Sci Rep. 2021; 11(1):18491.
PMID: 34531437
PMC: 8445954.
DOI: 10.1038/s41598-021-97471-5.
MAEA is an E3 ubiquitin ligase promoting autophagy and maintenance of haematopoietic stem cells.
Wei Q, Pinho S, Dong S, Pierce H, Li H, Nakahara F
Nat Commun. 2021; 12(1):2522.
PMID: 33947846
PMC: 8097058.
DOI: 10.1038/s41467-021-22749-1.
E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
Ahmed S, Buetow L, Gabrielsen M, Lilla S, Sibbet G, Sumpton D
Oncogene. 2021; 40(12):2149-2164.
PMID: 33627783
PMC: 7994203.
DOI: 10.1038/s41388-021-01684-x.
CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.
Belizaire R, Koochaki S, Udeshi N, Vedder A, Sun L, Svinkina T
Blood. 2021; 137(16):2209-2220.
PMID: 33512474
PMC: 8063090.
DOI: 10.1182/blood.2020006528.
C-Cbl regulates c-MPL receptor trafficking and its internalization.
Marklin M, Tandler C, Kopp H, Hoehn K, Quintanilla-Martinez L, Borst O
J Cell Mol Med. 2020; 24(21):12491-12503.
PMID: 32954656
PMC: 7687000.
DOI: 10.1111/jcmm.15785.
Hematopoietic Stem and Progenitor Cells Exhibit Stage-Specific Translational Programs via mTOR- and CDK1-Dependent Mechanisms.
Spevak C, Elias H, Kannan L, Ali M, Martin G, Selvaraj S
Cell Stem Cell. 2020; 26(5):755-765.e7.
PMID: 32386556
PMC: 9435590.
DOI: 10.1016/j.stem.2019.12.006.
The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations.
Weisberg E, Meng C, Case A, Tiv H, Gokhale P, Toure A
J Cell Mol Med. 2020; 24(3):2145-2156.
PMID: 31943762
PMC: 7011134.
DOI: 10.1111/jcmm.14820.
A20 deficiency in hematopoietic stem cells causes lymphopenia and myeloproliferation due to elevated Interferon-γ signals.
Nakagawa M, Rathinam C
Sci Rep. 2019; 9(1):12658.
PMID: 31477755
PMC: 6718430.
DOI: 10.1038/s41598-019-49038-8.
Constitutive Activation of the Canonical NF-κB Pathway Leads to Bone Marrow Failure and Induction of Erythroid Signature in Hematopoietic Stem Cells.
Nakagawa M, Rathinam C
Cell Rep. 2018; 25(8):2094-2109.e4.
PMID: 30463008
PMC: 6945759.
DOI: 10.1016/j.celrep.2018.10.071.
Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL.
Siekmann I, Dierck K, Prall S, Klokow M, Strauss J, Buhs S
Blood Adv. 2018; 2(19):2554-2567.
PMID: 30301811
PMC: 6177654.
DOI: 10.1182/bloodadvances.2018020693.
Phosphorylation control of the ubiquitin ligase Cbl is conserved in choanoflagellates.
Amacher J, Hobbs H, Cantor A, Shah L, Rivero M, Mulchand S
Protein Sci. 2018; 27(5):923-932.
PMID: 29498112
PMC: 5916117.
DOI: 10.1002/pro.3397.
Sleeping through the storm: Preventing myelosuppression with quizartinib.
Taylor S, Langdon W
Oncotarget. 2017; 8(51):88255-88256.
PMID: 29179431
PMC: 5687601.
DOI: 10.18632/oncotarget.21395.
CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K, Jiang J, Donaghy R, Riling C, Cheng Y, Chandra V
Genes Dev. 2017; 31(10):1007-1023.
PMID: 28611190
PMC: 5495118.
DOI: 10.1101/gad.297135.117.
Modeling activating mutations in vivo.
Chun-Wei Lee S, Abdel-Wahab O
Blood. 2017; 129(15):2046-2048.
PMID: 28408421
PMC: 5391629.
DOI: 10.1182/blood-2017-03-770222.